Developer docs
API playgroundTry for free, no card

Search company profiles

PathNet

Full company profile

uuid000csly

Namestring
PathNet
Legal namestring
PathNet Inc
Websiteurl
pathnetlab.com
Company typeenum
Private
Founded yearint
2019
Descriptiontext

PathNet is a privately held digital pathology laboratory network founded in 2019 (spun out from Lumea) and headquartered in Little Rock, Arkansas, operating a national footprint across 27 US states. The company provides turnkey digital pathology, laboratory, and business support services primarily to independent pathology practices and specialty clinics in urology, dermatology, and gastroenterology. Its core technical platform combines cloud-based whole-slide imaging for remote digital sign-out via iPad or monitor, the BxLink Laboratory Information System for specimen-to-report workflow, and proprietary pre-analytic tools (BxBoard® tissue collection device and BxChip® clinical tissue array) that preserve tissue orientation and reduce handling overhead for prostate biopsies.

The platform's clinical workflow integrates third-party AI capabilities through strategic partnerships: AIRA Matrix for prostate cancer detection and Gleason grading, Valar Labs for bladder cancer risk stratification and BCG response prediction, AIxMed for AI-powered urine cytology under The Paris System, Tempus Edge Platform for biomarker identification, and Alpenglow Biosciences for 3D volumetric tissue imaging. PathNet reports diagnostic accuracy 20-40% above national averages in certain specialties and 24-48 hour lab-to-report turnaround for prostate biopsies, with full federal CLIA certification and state licensure in California, Maryland, DC, and New York. Its TruCore pathology network operates as an embedded flagship customer and affiliated group.

The business model combines recurring subscription revenue from laboratory diagnostic services and digital pathology platform access with professional services revenue from business support offerings (billing, collections, licensing, marketing). Distribution is via direct enterprise sales to pathology groups and clinics, with no publicly disclosed pricing. The company is founder/management-controlled with no disclosed institutional funding rounds and CEO Jason A. Camilletti (appointed August 2022, succeeded founder Dr. Matthew O. Leavitt who remains Chairman).

Short descriptiontext

PathNet is a privately held digital pathology laboratory network providing turnkey digital sign-out, proprietary tissue handling tools, and AI-integrated diagnostics to independent pathology practices and urology, dermatology, and gastroenterology clinics across 27 US states.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersLittle Rock, United States
HQ citystring
Little Rock
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
digital pathology, laboratory diagnostics, anatomic pathology, cancer diagnostics, pathology laboratory
Industry4 codes
PRIMARYHLACAMAJ
Pathology Reporting, Synoptic Templates & Cancer Registry Interfaces
Healthcare & Life Sciences/Digital Health & Health IT/Laboratory Information Systems (LIS/LIMS) & Pathology Informatics
SECONDARYHLACALAI
Image Exchange, Sharing & Patient/Provider Portals (DICOM/Web)
Healthcare & Life Sciences/Digital Health & Health IT/Medical Imaging Informatics (PACS/RIS/VNA) & Radiology IT
SECONDARYHLAAAMAI
Molecular Pathology & Tissue Biomarkers (IHC/ISH, digital pathology-linked markers)
Healthcare & Life Sciences/Biotechnology & Biologics/Biomarkers and Companion Diagnostics
SECONDARYHLALAGAN
Urology Telemedicine Platforms
Healthcare & Life Sciences/Telehealth Platforms/Specialty Telemedicine Platforms (e.g., dermatology, cardiology, neurology)
NAICS code1 code
  • Medical and Diagnostic Laboratories6215
SIC code1 code
  • Services-Medical Laboratories8071
Product category
Digital Pathology Laboratory Services
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Laboratory Diagnostic Services
TypeSubscription Recurring
Description

Provides pathology laboratory services including tissue processing, slide preparation, and digital scanning for pathology groups. Specimens are shipped to PathNet laboratories and results returned within 24-48 hours.

pathnetlab.com
2Digital Pathology Platform Access
TypeSubscription Recurring
Description

Software-as-a-service access to digital pathology sign-out platform with AI integration capabilities for quality assurance and remote collaboration.

pathnetlab.com
3Business Support Services
TypeProfessional Services
Description

Billing, collections, accounting, licensing, marketing support, and customer support services for independent pathology practices.

pathnetlab.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

PathNet operates a national digital pathology laboratory network that delivers whole-slide digital imaging, cloud-based remote case sign-out, AI-integrated quality assurance, tissue processing using proprietary BxBoard/BxChip collection devices, and administrative business support services. The company processes specimens shipped from urology, dermatology, and gastroenterology practices and returns diagnostic results within 24-48 hours across 27 US states.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 20-40% higher cancer detection rates than national average in certain specialties
+3 more records
Product overview1 text field

PathNet is a digital pathology laboratory network offering a unified platform combining digital pathology sign-out, laboratory diagnostics, and business support services. The core offerings include the Digital Pathology Platform for cloud-based case review and remote sign-out, BxLink Laboratory Information System for workflow management, and specialized tissue collection/processing tools (BxBoard, BxChip). AI capabilities are delivered through strategic partnerships including AIRA Matrix's AI Prostate Suite for computer vision-based prostate cancer detection and grading, Valar Labs' Vesta portfolio for bladder cancer prognostic and predictive analytics, AIxMed's AIxURO for urine cytology analysis, and Alpenglow Biosciences' 3D volumetric imaging for advanced spatial analytics. The company also provides business support services (billing, marketing, licensing) and operates TruCore, a network of affiliated pathology practices. The platform serves urology, dermatology, and gastroenterology specialties across 27 US states.

Product and service13 records
1Digital Pathology Platform
CategoryDigital Pathology Software
Description

Whole-slide digital imaging and cloud-based pathology platform enabling pathologists to sign out cases remotely on computer monitors or iPad Pro tablets, with automated measurements, AI-assisted report generation, and AI integration for quality assurance. Built for independent pathology groups seeking to modernize microscopy workflows.

2BxLink Laboratory Information System (LIS)
CategoryLaboratory Information System
Description

Laboratory information system supporting pathology workflow from specimen intake to report generation, integrating electronic patient data with physical specimens, enabling order management, encounter creation, and specimen tracking across urology, dermatology, dermatopathology, and surgical pathology specialties. Integrates with EMR/EHR systems.

3BxBoard Tissue Collection Device
CategoryPre-Analytic Tissue Collection Device
Description

Patented tissue collection device that holds six prostate biopsy cores, reducing specimen jars from 12-24 to 2-3 boards per procedure while preserving tissue orientation for accurate diagnosis.

4BxChip Clinical Tissue Array
CategoryPre-Analytic Tissue Processing
Description

Clinical tissue array made of artificial tissue-like material that receives and holds multiple tissue cores, enabling processing, embedding and sectioning as a single standard tissue while maintaining orientation. Allows up to 18 prostate cores on a single glass slide.

5Laboratory Diagnostic Services
CategoryDiagnostic Laboratory Services
Description

National pathology laboratory services including tissue processing, slide preparation, and digital scanning for pathology groups. Specimens are shipped to PathNet's laboratories and digital results returned within 24-48 hours for prostate biopsies.

6Business Support Services
CategoryBusiness Support Services
Description

Administrative and operational support services for independent pathology practices including billing, collections, bookkeeping, licensing, onboarding, training, marketing, website management, and patient education materials.

7TruCore Pathology Network
CategoryPathology Practice Network
Description

Network of forward-thinking pathologists leveraging PathNet's digital laboratory solutions, providing virtual collaboration between pathologists, clinicians, and patients with timely diagnostic insights. Operates with its own CLIA certification (04D2299038).

8AI Prostate Suite (AIRA Matrix)
CategoryAI Diagnostic Service
Description

AI-powered prostate cancer detection and grading suite providing computer vision analysis of digital pathology slides. Offers second-opinion AI review for cancer detection and Gleason score classification during prostate biopsy diagnosis.

9Vesta Bladder Cancer Diagnostics (Valar Labs)
CategoryAI Diagnostic Service
Description

AI-powered diagnostic portfolio for non-muscle invasive bladder cancer (NMIBC) including Vesta Bladder Risk Stratify (prognostic risk stratification) and Vesta Bladder BCGPredict (BCG therapy response prediction). Computational pathology analysis for personalized bladder cancer management.

10AIxURO Urine Cytology (AIxMed)
CategoryAI Diagnostic Service
Description

AI-powered urine cytology analysis technology for bladder cancer diagnostics utilizing The Paris System (TPS) for standardized reporting. Designed to improve diagnostic accuracy, workflow efficiency, and reduce invasive cystoscopy procedures.

113D AI Cancer Diagnostics (Alpenglow)
CategoryAI Diagnostic Service
Description

3D volumetric tissue imaging and AI-powered spatial analytics for prostate and bladder cancer diagnostics. Includes co-developed 3D AI prostate cancer predictive assay and 3D digital biomarker for bladder carcinoma in situ (CIS).

12Tempus Edge Platform Integration
CategoryAI Diagnostic Service
Description

Access to Tempus Edge platform providing AI models for identifying specimens with actionable biomarkers using H&E stained slides. Part of computational pathology capabilities for biomarker identification and therapeutic decision support.

13URO17 Bladder Biomarker Test
CategoryMolecular Diagnostic Test
Description

Bladder cancer biomarker test offered through ancillary and molecular testing pathways for bladder cancer detection and monitoring.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership6 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-01-08
Description

Strategic partnership to develop, validate, and commercialize 3D AI-enabled diagnostic tests for prostate and bladder cancer. PathNet will deploy an Alpenglow-ZEISS 3D microscope in its Little Rock laboratory for true volumetric tissue imaging at clinical scale. Co-development includes a 3D AI prostate cancer predictive assay and a 3D digital biomarker for bladder carcinoma in situ (CIS).

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-12-22
Description

Strategic partnership to deliver AI-powered bladder cancer diagnostics nationwide. PathNet's national laboratory network will provide access to Vesta Bladder Risk Stratify and Vesta Bladder BCGPredict for non-muscle invasive bladder cancer management. Combines Valar Labs' computational pathology capabilities with PathNet's laboratory infrastructure.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2025-11-03
Description

Strategic partnership to enhance digital pathology services with AIxMed's AIxURO™ technology for AI-powered urine cytology analysis. The integration aims to improve bladder cancer diagnostics and workflow efficiency, supporting clinical decision-making and potentially reducing invasive procedures.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2025-03-21
Description

Collaboration to provide AI-powered prostate cancer diagnosis using AIRA Matrix's AI Prostate Suite. The partnership arms PathNet pathologists with cutting-edge AI tools for detecting and grading cancer, providing a second set of digital eyes for improved diagnostic accuracy and Gleason scoring.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2022-03-28
Description

Collaboration on Uruguay's first clinical validation study of a fully digital diagnostic platform using Motic's EasyScan Pro 6 whole-slide imaging system. Study involves 50 patients comparing digital sign-out and traditional pathology methods.

6TruCore Pathology Group
Strategic tierCoreTypeStrategic or Co-development Partner
Description

TruCore is a group of forward-thinking pathologists leveraging PathNet's digital laboratory solutions. TruCore pathologists virtually work alongside clinical colleagues, providing timely insights and diagnostic intelligence through PathNet's platform.

pathnetlab.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Inform Diagnostics (formerly Caris MPI / Pathology Inc.) is a national subspecialty pathology lab serving dermatologists, urologists, gastroenterologists, and other specialists. Directly comparable to PathNet on vertical, specialty, and client base of independent clinics sending biopsy specimens.

TypeRegional player
Description

ARUP is a large academic/clinical reference laboratory affiliated with the University of Utah, providing specialty and anatomic pathology services. Comparable to PathNet on specialty testing depth and CLIA-grade lab services, but with a distinct regional/academic orientation rather than a national independent-practice focus.

TypeDirect peer
Description

PathAI builds AI-powered pathology tools for diagnostic and biopharma applications, including prostate and oncology indications. Compares to PathNet on AI pathology focus and biopharma-adjacent datasets, though PathAI skews more toward research/pharma than independent clinical practices.

TypeBroad incumbent
Description

NeoGenomics is a specialty oncology diagnostics laboratory serving hospitals, oncologists, and pathologists with molecular and surgical pathology services. Comparable to PathNet on specialty oncology lab focus, though at meaningfully larger scale and with broader oncology/precision medicine scope.

TypeEmerging player
Description

AIRA Matrix develops AI Prostate Suite and other computational pathology algorithms deployed in prostate cancer grading workflows. Comparable as a direct AI technology partner to PathNet and as an emerging AI pathology vendor serving a similar pathologist customer base.

TypeBroad incumbent
Description

Quest Diagnostics is one of the largest reference laboratory networks in the US, providing clinical and anatomic pathology nationwide with multi-state CLIA infrastructure. Comparable as a national lab competitor PathNet would compete against on routine pathology send-outs.

TypeDirect peer
Description

Ibex develops AI algorithms for cancer detection and grading across breast, prostate, and other tissues, deployed as a second-reader/QA layer in pathology workflows. Directly comparable to PathNet's AIRA Matrix and AIxMed-powered AI QA stack on technology and target users.

TypeDirect peer
Description

Proscia offers a digital pathology platform (Concentriq) used by pathology labs and biopharma for whole-slide image management, AI integration, and remote collaboration. It is directly comparable to PathNet's digital pathology platform and LIS workflow on product and customer base, though it is software-only rather than a lab.

9Tempus AI
TypeBroad incumbent
Description

Tempus is an AI-driven precision medicine company offering genomics, pathology, and data services including the Tempus Edge platform, which PathNet integrates with. Comparable as a digital pathology AI partner and as a broader force in computational pathology, though at larger scale.

TypeBroad incumbent
Description

Labcorp operates one of the largest US clinical and anatomic pathology reference lab networks. Comparable on national lab scale, multi-state operations, and broad physician/clinic outreach that competes with PathNet for specialty biopsy volume.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration2 records

Each record includes

Title, Type, Description, Source

AI capability10 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles10 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance6 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

PathNet

Digital Pathology Laboratory Servicespathnetlab.com

PathNet is a privately held digital pathology laboratory network providing turnkey digital sign-out, proprietary tissue handling tools, and AI-integrated diagnostics to independent pathology practices and urology, dermatology, and gastroenterology clinics across 27 US states.

What PathNet does

PathNet is a privately held digital pathology laboratory network founded in 2019 (spun out from Lumea) and headquartered in Little Rock, Arkansas, operating a national footprint across 27 US states. The company provides turnkey digital pathology, laboratory, and business support services primarily to independent pathology practices and specialty clinics in urology, dermatology, and gastroenterology. Its core technical platform combines cloud-based whole-slide imaging for remote digital sign-out via iPad or monitor, the BxLink Laboratory Information System for specimen-to-report workflow, and proprietary pre-analytic tools (BxBoard® tissue collection device and BxChip® clinical tissue array) that preserve tissue orientation and reduce handling overhead for prostate biopsies.

The platform's clinical workflow integrates third-party AI capabilities through strategic partnerships: AIRA Matrix for prostate cancer detection and Gleason grading, Valar Labs for bladder cancer risk stratification and BCG response prediction, AIxMed for AI-powered urine cytology under The Paris System, Tempus Edge Platform for biomarker identification, and Alpenglow Biosciences for 3D volumetric tissue imaging. PathNet reports diagnostic accuracy 20-40% above national averages in certain specialties and 24-48 hour lab-to-report turnaround for prostate biopsies, with full federal CLIA certification and state licensure in California, Maryland, DC, and New York. Its TruCore pathology network operates as an embedded flagship customer and affiliated group.

The business model combines recurring subscription revenue from laboratory diagnostic services and digital pathology platform access with professional services revenue from business support offerings (billing, collections, licensing, marketing). Distribution is via direct enterprise sales to pathology groups and clinics, with no publicly disclosed pricing. The company is founder/management-controlled with no disclosed institutional funding rounds and CEO Jason A. Camilletti (appointed August 2022, succeeded founder Dr. Matthew O. Leavitt who remains Chairman).

PathNet firmographics

Firmographics
Name
PathNet
Legal name
PathNet Inc
Website
https://pathnetlab.com
Company type
Private
Founded year
2019
Operating status
Operating
Headcount range
11–50 employees
Short description
PathNet is a privately held digital pathology laboratory network providing turnkey digital sign-out, proprietary tissue handling tools, and AI-integrated diagnostics to independent pathology practices and urology, dermatology, and gastroenterology clinics across 27 US states.
Ownership category
akta.pro rank

PathNet industry classification

Industry
Product category
Digital Pathology Laboratory Services
NAICS
Medical and Diagnostic Laboratories (6215)
SIC
Services-Medical Laboratories (8071)
akta.pro industry
PRIMARYHLACAMAJ
Pathology Reporting, Synoptic Templates & Cancer Registry Interfaces
Healthcare & Life Sciences/Digital Health & Health IT/Laboratory Information Systems (LIS/LIMS) & Pathology Informatics
SECONDARYHLACALAI
Image Exchange, Sharing & Patient/Provider Portals (DICOM/Web)
Healthcare & Life Sciences/Digital Health & Health IT/Medical Imaging Informatics (PACS/RIS/VNA) & Radiology IT
SECONDARYHLAAAMAI
Molecular Pathology & Tissue Biomarkers (IHC/ISH, digital pathology-linked markers)
Healthcare & Life Sciences/Biotechnology & Biologics/Biomarkers and Companion Diagnostics
SECONDARYHLALAGAN
Urology Telemedicine Platforms
Healthcare & Life Sciences/Telehealth Platforms/Specialty Telemedicine Platforms (e.g., dermatology, cardiology, neurology)

Keywords

  • Digital pathology
  • Laboratory diagnostics
  • Anatomic pathology
  • Cancer diagnostics
  • Pathology laboratory

Where PathNet is headquartered

Location

Headquarters

HQ city
Little Rock
HQ country
United States
HQ region
North America

Offices1 record

Markets served

PathNet business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Laboratory Diagnostic Services: Provides pathology laboratory services including tissue processing, slide preparation, and digital scanning for pathology groups. Specimens are shipped to PathNet laboratories and results returned within 24-48 hours.
  2. Digital Pathology Platform Access: Software-as-a-service access to digital pathology sign-out platform with AI integration capabilities for quality assurance and remote collaboration.
  3. Business Support Services: Billing, collections, accounting, licensing, marketing support, and customer support services for independent pathology practices.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

PathNet product offering

Product offering

Core offering

PathNet operates a national digital pathology laboratory network that delivers whole-slide digital imaging, cloud-based remote case sign-out, AI-integrated quality assurance, tissue processing using proprietary BxBoard/BxChip collection devices, and administrative business support services. The company processes specimens shipped from urology, dermatology, and gastroenterology practices and returns diagnostic results within 24-48 hours across 27 US states.

Product overview

PathNet is a digital pathology laboratory network offering a unified platform combining digital pathology sign-out, laboratory diagnostics, and business support services. The core offerings include the Digital Pathology Platform for cloud-based case review and remote sign-out, BxLink Laboratory Information System for workflow management, and specialized tissue collection/processing tools (BxBoard, BxChip). AI capabilities are delivered through strategic partnerships including AIRA Matrix's AI Prostate Suite for computer vision-based prostate cancer detection and grading, Valar Labs' Vesta portfolio for bladder cancer prognostic and predictive analytics, AIxMed's AIxURO for urine cytology analysis, and Alpenglow Biosciences' 3D volumetric imaging for advanced spatial analytics. The company also provides business support services (billing, marketing, licensing) and operates TruCore, a network of affiliated pathology practices. The platform serves urology, dermatology, and gastroenterology specialties across 27 US states.

Differentiator

Problem solved

Functional benefit

Products and services

  • Digital Pathology Platform Whole-slide digital imaging and cloud-based pathology platform enabling pathologists to sign out cases remotely on computer monitors or iPad Pro tablets, with automated measurements, AI-assisted report generation, and AI integration for quality assurance. Built for independent pathology groups seeking to modernize microscopy workflows.
  • BxLink Laboratory Information System (LIS) Laboratory information system supporting pathology workflow from specimen intake to report generation, integrating electronic patient data with physical specimens, enabling order management, encounter creation, and specimen tracking across urology, dermatology, dermatopathology, and surgical pathology specialties. Integrates with EMR/EHR systems.
  • BxBoard Tissue Collection Device Patented tissue collection device that holds six prostate biopsy cores, reducing specimen jars from 12-24 to 2-3 boards per procedure while preserving tissue orientation for accurate diagnosis.
  • BxChip Clinical Tissue Array Clinical tissue array made of artificial tissue-like material that receives and holds multiple tissue cores, enabling processing, embedding and sectioning as a single standard tissue while maintaining orientation. Allows up to 18 prostate cores on a single glass slide.
  • Laboratory Diagnostic Services National pathology laboratory services including tissue processing, slide preparation, and digital scanning for pathology groups. Specimens are shipped to PathNet's laboratories and digital results returned within 24-48 hours for prostate biopsies.
  • Business Support Services Administrative and operational support services for independent pathology practices including billing, collections, bookkeeping, licensing, onboarding, training, marketing, website management, and patient education materials.
  • TruCore Pathology Network Network of forward-thinking pathologists leveraging PathNet's digital laboratory solutions, providing virtual collaboration between pathologists, clinicians, and patients with timely diagnostic insights. Operates with its own CLIA certification (04D2299038).
  • AI Prostate Suite (AIRA Matrix) AI-powered prostate cancer detection and grading suite providing computer vision analysis of digital pathology slides. Offers second-opinion AI review for cancer detection and Gleason score classification during prostate biopsy diagnosis.
  • Vesta Bladder Cancer Diagnostics (Valar Labs) AI-powered diagnostic portfolio for non-muscle invasive bladder cancer (NMIBC) including Vesta Bladder Risk Stratify (prognostic risk stratification) and Vesta Bladder BCGPredict (BCG therapy response prediction). Computational pathology analysis for personalized bladder cancer management.
  • AIxURO Urine Cytology (AIxMed) AI-powered urine cytology analysis technology for bladder cancer diagnostics utilizing The Paris System (TPS) for standardized reporting. Designed to improve diagnostic accuracy, workflow efficiency, and reduce invasive cystoscopy procedures.
  • 3D AI Cancer Diagnostics (Alpenglow) 3D volumetric tissue imaging and AI-powered spatial analytics for prostate and bladder cancer diagnostics. Includes co-developed 3D AI prostate cancer predictive assay and 3D digital biomarker for bladder carcinoma in situ (CIS).
  • Tempus Edge Platform Integration Access to Tempus Edge platform providing AI models for identifying specimens with actionable biomarkers using H&E stained slides. Part of computational pathology capabilities for biomarker identification and therapeutic decision support.
  • URO17 Bladder Biomarker Test Bladder cancer biomarker test offered through ancillary and molecular testing pathways for bladder cancer detection and monitoring.

Quantifiable outcome

  • 20-40% higher cancer detection rates than national average in certain specialties
  • +3 more outcomes

Companies that use PathNet

Customer profile

Named customers5 records

Segments4 records

Ideal customer profiles4 records

PathNet technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability10 records

Feature6 records

PathNet partnerships and signals

Strategic signal

Partnerships

Six partnerships are on record, tiered core and minor.

  • Alpenglow BiosciencescoreStrategic or Co-development Partner · 8 January 2026Strategic partnership to develop, validate, and commercialize 3D AI-enabled diagnostic tests for prostate and bladder cancer. PathNet will deploy an Alpenglow-ZEISS 3D microscope in its Little Rock laboratory for true volumetric tissue imaging at clinical scale. Co-development includes a 3D AI prostate cancer predictive assay and a 3D digital biomarker for bladder carcinoma in situ (CIS).
  • Valar LabscoreStrategic or Co-development Partner · 22 December 2025Strategic partnership to deliver AI-powered bladder cancer diagnostics nationwide. PathNet's national laboratory network will provide access to Vesta Bladder Risk Stratify and Vesta Bladder BCGPredict for non-muscle invasive bladder cancer management. Combines Valar Labs' computational pathology capabilities with PathNet's laboratory infrastructure.
  • AIxMedcoreTechnology or Integration · 3 November 2025Strategic partnership to enhance digital pathology services with AIxMed's AIxURO™ technology for AI-powered urine cytology analysis. The integration aims to improve bladder cancer diagnostics and workflow efficiency, supporting clinical decision-making and potentially reducing invasive procedures.
  • AIRA MatrixcoreTechnology or Integration · 21 March 2025Collaboration to provide AI-powered prostate cancer diagnosis using AIRA Matrix's AI Prostate Suite. The partnership arms PathNet pathologists with cutting-edge AI tools for detecting and grading cancer, providing a second set of digital eyes for improved diagnostic accuracy and Gleason scoring.
  • MoticminorStrategic or Co-development Partner · 28 March 2022Collaboration on Uruguay's first clinical validation study of a fully digital diagnostic platform using Motic's EasyScan Pro 6 whole-slide imaging system. Study involves 50 patients comparing digital sign-out and traditional pathology methods.
  • TruCore Pathology GroupcoreStrategic or Co-development PartnerTruCore is a group of forward-thinking pathologists leveraging PathNet's digital laboratory solutions. TruCore pathologists virtually work alongside clinical colleagues, providing timely insights and diagnostic intelligence through PathNet's platform.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

PathNet competitors and assessment

Company assessment

Direct peers

  • Inform Diagnostics: Inform Diagnostics (formerly Caris MPI / Pathology Inc.) is a national subspecialty pathology lab serving dermatologists, urologists, gastroenterologists, and other specialists. Directly comparable to PathNet on vertical, specialty, and client base of independent clinics sending biopsy specimens.
  • PathAI: PathAI builds AI-powered pathology tools for diagnostic and biopharma applications, including prostate and oncology indications. Compares to PathNet on AI pathology focus and biopharma-adjacent datasets, though PathAI skews more toward research/pharma than independent clinical practices.
  • Ibex Medical Analytics: Ibex develops AI algorithms for cancer detection and grading across breast, prostate, and other tissues, deployed as a second-reader/QA layer in pathology workflows. Directly comparable to PathNet's AIRA Matrix and AIxMed-powered AI QA stack on technology and target users.
  • Proscia: Proscia offers a digital pathology platform (Concentriq) used by pathology labs and biopharma for whole-slide image management, AI integration, and remote collaboration. It is directly comparable to PathNet's digital pathology platform and LIS workflow on product and customer base, though it is software-only rather than a lab.

Regional players

  • ARUP Laboratories: ARUP is a large academic/clinical reference laboratory affiliated with the University of Utah, providing specialty and anatomic pathology services. Comparable to PathNet on specialty testing depth and CLIA-grade lab services, but with a distinct regional/academic orientation rather than a national independent-practice focus.

Broad incumbents

  • NeoGenomics: NeoGenomics is a specialty oncology diagnostics laboratory serving hospitals, oncologists, and pathologists with molecular and surgical pathology services. Comparable to PathNet on specialty oncology lab focus, though at meaningfully larger scale and with broader oncology/precision medicine scope.
  • Quest Diagnostics: Quest Diagnostics is one of the largest reference laboratory networks in the US, providing clinical and anatomic pathology nationwide with multi-state CLIA infrastructure. Comparable as a national lab competitor PathNet would compete against on routine pathology send-outs.
  • Tempus AI: Tempus is an AI-driven precision medicine company offering genomics, pathology, and data services including the Tempus Edge platform, which PathNet integrates with. Comparable as a digital pathology AI partner and as a broader force in computational pathology, though at larger scale.
  • Labcorp Diagnostics: Labcorp operates one of the largest US clinical and anatomic pathology reference lab networks. Comparable on national lab scale, multi-state operations, and broad physician/clinic outreach that competes with PathNet for specialty biopsy volume.

Emerging players

  • AIRA Matrix: AIRA Matrix develops AI Prostate Suite and other computational pathology algorithms deployed in prostate cancer grading workflows. Comparable as a direct AI technology partner to PathNet and as an emerging AI pathology vendor serving a similar pathologist customer base.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

PathNet social profiles

Digital presence

PathNet compliance and trust

Trust signal

Compliance6 records

PathNet financial estimates

Financial estimate

Revenue estimate

Valuation estimate

PathNet leadership team

Management profile

Number of profiles

Profiles10 records

PathNet subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

PathNet funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

PathNet M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about PathNet

What does PathNet do?

PathNet operates a national digital pathology laboratory network that delivers whole-slide digital imaging, cloud-based remote case sign-out, AI-integrated quality assurance, tissue processing using proprietary BxBoard/BxChip collection devices, and administrative business support services. The company processes specimens shipped from urology, dermatology, and gastroenterology practices and returns diagnostic results within 24-48 hours across 27 US states.

Is PathNet a public or private company?

PathNet is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was PathNet founded?

PathNet was founded in 2019. It employs 11 to 50 people.

Where is PathNet based?

PathNet is headquartered in Little Rock, United States, in the North America region.

How does PathNet make money?

Three revenue lines are on record. Laboratory Diagnostic Services are the primary driver. The others are digital Pathology Platform Access and business Support Services.

Who are PathNet's main competitors?

Direct peers on record are Inform Diagnostics, PathAI, Ibex Medical Analytics and Proscia. ARUP Laboratories is listed as a regional player. Broad incumbents are NeoGenomics, Quest Diagnostics, Tempus AI and Labcorp Diagnostics. AIRA Matrix is listed as an emerging player.

Does PathNet have an API?

No public API is recorded for PathNet.

What industry is PathNet in?

PathNet's product category is Digital Pathology Laboratory Services. Its primary akta.pro industry code is HLACAMAJ, Pathology Reporting, Synoptic Templates & Cancer Registry Interfaces, with a secondary code of HLACALAI, Image Exchange, Sharing & Patient/Provider Portals (DICOM/Web). Its NAICS code is 6215 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
EIN PresswirePathNet Expands Urologic Pathology Offerings with PTEN and FGFR3 Biomarkers for Prostate and Bladder CancerPathNet announced it will offer PTEN and FGFR3 biomarker staining in-house for prostate and bladder cancer. The PTEN stain assesses protein loss linked to tumor aggressiveness, while FGFR3 helps differentiate low-grade from high-grade papillary urothelial carcinoma. The company said bringing these tests in-house improves patient care and treatment decisions.GeekWireSeattle’s Alpenglow moves 3D microscope tech from lab to clinic to help modernize cancer diagnosticsSeattle-based Alpenglow Biosciences announced a partnership with PathNet to commercialize its 3D microscope technology for clinical prostate and bladder cancer diagnostics at PathNet's Little Rock, Arkansas laboratory. The startup, which spun out of the University of Washington in 2018 and has 22 employees with approximately $10 million raised from investors, also confirmed $250,000 in new funding from Mike Rice, a former BioLife Solutions CEO and Alpenglow advisory board member. Alpenglow, which has been collaborating with Zeiss on microscope hardware and analytics software, aims to enter clinical settings this year and secure regulatory approval next year as part of its broader push to modernize cancer diagnostics under its involvement in the Biden administration's Cancer Moonshot project.Clinical Lab ProductsValar Labs Partners with PathNet Lab to Expand AI Bladder Cancer DiagnosticsValar Labs has formed a strategic partnership with PathNet Lab to deliver AI-powered bladder cancer diagnostic tools through PathNet's national laboratory network. The collaboration will provide clinicians access to Vesta Bladder Risk Stratify and Vesta Bladder BCGPredict, designed to help urologists and oncologists incorporate AI-driven prognostic and predictive insights into clinical decision-making for non-muscle invasive bladder cancer management. The partnership combines Valar Labs' computational pathology capabilities with PathNet's established laboratory infrastructure to expand adoption of AI-powered diagnostics in bladder cancer care nationwide.Business Wire BlogValar Labs Announces Strategic Partnership with PathNet Lab to Deliver AI-Driven Bladder Cancer Insights NationwideValar Labs announced a strategic partnership with PathNet Lab to deploy its AI-powered Vesta diagnostic portfolio for non-muscle invasive bladder cancer (NMIBC) across PathNet's national clinical network. The collaboration grants PathNet's network of urologists and oncologists access to Vesta Bladder Risk Stratify and Vesta Bladder BCGPredict tools, enabling AI-driven prognostic and predictive insights in clinical decision-making. Both companies stated the partnership aims to advance personalized bladder cancer care and expand adoption of computational pathology diagnostics nationwide.PR NewswireAIxMed and PathNet Partnership: Advancing Digital Pathology with AI-Powered Urine CytologyAIxMed and PathNet announced a partnership to integrate AIxMed's AIxURO urine cytology software into PathNet's digital pathology platform. The software uses The Paris System for Reporting Urinary Cytology to identify suspicious cells, aiming to improve diagnostic accuracy and reduce invasive procedures like cystoscopies.